Hallgeir Rui

机构：Thomas Jefferson University · ORCID：0000-0002-8778-261X

发表论文 439 篇 · 总被引 9716 次 · h-index 58

代表论文

• Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells (2025 · Cancer Research · 被引 3)
• Abstract 6466: Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancer (2026 · Cancer Research · 被引 1)
• Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study. (2026 · Journal of Clinical Oncology)
• Safety and 5-year survival following treatment with leronlimab plus physician’s choice combination therapy in patients with metastatic triple-negative breast cancer. (2026 · Journal of Clinical Oncology)
• Abstract 1751: Deletion of the DACH1 gene tumor suppressor increases replication fork stress, epithelial mesenchymal transition and sensitivity to WEE1 kinase inhibitors in prostate cancer (2026 · Cancer Research)
• Abstract 2265: Stromal cyclin D1 promotes prostate cancer stemness via the transcriptional regulatory E domain. (2026 · Cancer Research)